Iterum Therapeutics Plc (NASDAQ: ITRM) reported Q4 EPS of ($0.12), $0.10 better than the analyst estimate of ($0.22).

For earnings history and earnings-related data on Iterum Therapeutics Plc (ITRM) click here.